The Serum Institute of India has responded to "malicious and misconceived" allegations by preparing a ₹ 100 crore defamation suit against a Covishield coronavirus vaccine trial participant who claimed to suffer a "virtual neurological breakdown" after being administered a dose.

NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt